Affiliation:
1. Belarusian State Medical University
2. Institute of Physiology of the National Academy of Sciences of Belarus
Abstract
In this article we analyze the bilirubin binding sites of human serum albumin from the point of view of the secondary structure instability, as well as the effect of amino acid substitutions caused by radiation exposure on the ability of albumin to bind bilirubin-IX-alpha. Based on calculations of binding energy and inhibition constants of bilirubin-albumin complexes before and after the amino acid substitutions, it was found that amino acid substitutions have different effects on the ability of human serum albumin to bind bilirubin. Amino acid substitutions Asp269-Gly269 (Nagasaki-1), Glu354-Lys354 (Hiroshima-1), Asp375-Asn375 (Nagasaki-2) reduce the binding free energy of bilirubin with human serum albumin, and the amino acid substitutions His3-Gln3 (Nagasaki-3) and Glu382-Lys382 (Hiroshima-2) increase it during molecular docking with the corresponding areas of the protein surface. The inhibition constants are significantly higher than with known binding sites. In general, mutations caused by radiation exposure cannot effect on bilirubin binding sites of human serum albumin, since the amino acid residues that are replaced do not interact with the amino acid residues from the binding sites (Leu115, Arg117, Phe134, Tyr138, Ile142, Phe149, Phe157, Tyr161, Arg186, Lys190, Lys240, Arg222). All amino acid residues from known binding sites are located in stable elements of the secondary structure of human serum albumin.The data obtained are important for understanding the impact of radiation exposure on the development of bilirubin encephalopathy in the population of the Chernobyl region and Japan.
Publisher
Publishing House Belorusskaya Nauka
Reference13 articles.
1. Caraceni P., Domenicali M., Tovoli A., Napoli L., Ricci C. S., Tufoni M., Bernardi M. Clinical indications for the albumin use: still a controversial issue. European Journal of Internal Medicine, 2013, vol. 24, no. 8, pp. 721–728. https://doi.org/10.1016/j.ejim.2013.05.015
2. He X. M., Carter D. C. Atomic structure and chemistry of human serum albumin. Nature, 1992, vol. 358, no. 6383, pp. 209–215. https://doi.org/10.1038/358209a0
3. Colmenarejo G. In silico prediction of drug-binding strengths to human serum albumin. Medicinal Research Reviews, 2003, vol. 23, no. 3, pp. 275–301. https://doi.org/10.1002/med.10039
4. Tkachenko A. K., Ustinovich A. A., Romanova O. N., Klyuchareva A. A., Novak L. V. Jaundice of the neonatal period: a teaching aid. Minsk, Belarusian State Medical University, 2017. 68 р. (in Russian).
5. Arai K., Madison J., Huss K., Ishioka N., Satoh C., Fujita M., Neel J. V., Sakurabayashi I., Putnam F. W. Point substitutions in Japanese alloalbumins. Proceedings of the National Academy of Sciences of the United States of America, 1989, vol. 86, no. 16, pp. 6092–6096. https://doi.org/10.1073/pnas.86.16.6092